Review
doi: 10.1016/0166-2236(91)90141-g.
The dopamine hypothesis of the reinforcing properties of cocaine
Affiliations
- PMID: 1719677
- DOI: 10.1016/0166-2236(91)90141-g
Item in Clipboard
Review
The dopamine hypothesis of the reinforcing properties of cocaine
Trends Neurosci.
1991 Jul.
Abstract
A variety of evidence suggests a 'dopamine hypothesis' for the reinforcing properties of cocaine. This hypothesis proposes that cocaine binds at the dopamine transporter and mainly inhibits neurotransmitter re-uptake; the resulting potentiation of dopaminergic neurotransmission in mesolimbocortical pathways ultimately causes reinforcement. This model suggests potential medications for treatment of cocaine abuse and dependence. Some, but not all, pharmacological data in humans support the hypothesis and additional experimentation is needed.
Similar articles
-
Molecular pharmacology of cocaine: a dopamine hypothesis and its implications.Ciba Found Symp. 1992;166:81-9; discussion 89-95. doi: 10.1002/9780470514245.ch6. Ciba Found Symp. 1992. PMID: 1638923 Review.
-
Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.J Neurosci. 2001 May 1;21(9):RC141: 1-4. doi: 10.1523/JNEUROSCI.21-09-j0001.2001. J Neurosci. 2001. PMID: 11312315 Free PMC article.
-
Studies of the biogenic amine transporters. II. A brief study on the use of [3H]DA-uptake-inhibition to transporter-binding-inhibition ratios for the in vitro evaluation of putative cocaine antagonists.Life Sci. 1993;53(17):PL267-72. doi: 10.1016/0024-3205(93)90602-y. Life Sci. 1993. PMID: 8412496
-
Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.Eur J Pharmacol. 2004 Feb 23;486(3):251-7. doi: 10.1016/j.ejphar.2004.01.003. Eur J Pharmacol. 2004. PMID: 14985046
-
The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates.J Pharmacol Exp Ther. 2001 Jul;298(1):1-6. J Pharmacol Exp Ther. 2001. PMID: 11408518 Review.
Cited by
-
Dopaminergic inhibition by G9a/Glp complex on tyrosine hydroxylase in nerve injury-induced hypersensitivity.Mol Pain. 2016 Aug 24;12:1744806916663731. doi: 10.1177/1744806916663731. Print 2016. Mol Pain. 2016. PMID: 27562335 Free PMC article.
-
Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters.Bioorg Med Chem. 2007 Jan 15;15(2):1067-82. doi: 10.1016/j.bmc.2006.10.016. Epub 2006 Oct 27. Bioorg Med Chem. 2007. PMID: 17070057 Free PMC article.
-
Acute effects of D-amphetamine on progressive-ratio performance maintained by cigarette smoking and money.Psychopharmacology (Berl). 2003 Jun;167(4):393-402. doi: 10.1007/s00213-003-1416-z. Epub 2003 Apr 9. Psychopharmacology (Berl). 2003. PMID: 12684732
-
Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter.Br J Pharmacol. 2009 Apr;156(7):1178-84. doi: 10.1111/j.1476-5381.2009.00124.x. Epub 2009 Feb 18. Br J Pharmacol. 2009. PMID: 19226282 Free PMC article.
-
Paradoxical abatement of striatal dopaminergic transmission by cocaine and methylphenidate.J Biol Chem. 2014 Jan 3;289(1):264-74. doi: 10.1074/jbc.M113.495499. Epub 2013 Nov 26. J Biol Chem. 2014. PMID: 24280216 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
